Blood tube testing reagents
Ended Awarded Last action
- Contract number
- 36C26122F0032
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $76,729
Award facts
- Contract value 78% obligated
-
- $76,729.37 Current, with exercised options
- $97,999.66 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,519 | |
| Exercise an Option | $23,601 | |
| Supplemental Agreement for work within scope | $1,903 | |
| Funding Only Action | -$9,187 | |
| Exercise an Option | $21,270 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$7,792 | |
| Exercise an Option | $21,270 | |
| Funding Only Action | -$8,358 | |
| Exercise an Option | $21,270 | |
| Original award | $21,270 |
Show all 11
About this award
Alba Bioscience, Inc., a Chicago-based in vitro diagnostic supplier, was awarded a delivery order valued at approximately $98K on October 1, 2021, for blood tube testing reagents under the General Services Administration's Schedule 65-VII (In Vitro Diagnostics, Reagents, and Tests). The contract, which runs through September 30, 2026, was issued by Veterans Integrated Service Network 21 on a firm fixed-price basis without set-aside designation. Alba Bioscience specializes in immunohematology reagents and blood banking materials essential for transfusion services and diagnostic testing, including monoclonal antibodies, antibody identification panels, antibody screening products, quality control kits, and additive solutions.
This delivery order represents continued federal procurement from Alba Bioscience, which maintains established relationships across multiple Veterans Integrated Service Networks and other federal healthcare agencies. The company currently operates under two broader Blanket Purchase Agreements with the Department of Veterans Affairs—one with Veterans Integrated Service Network 15 valued at approximately $200K through May 2030 and another with Veterans Integrated Service Network 10 valued at approximately $219K through September 2026—enabling multiple VA medical facilities to efficiently procure critical blood banking supplies through streamlined task order processes. The non-competitive nature of Alba Bioscience's awards reflects the specialized and limited market for these diagnostic products within the federal healthcare system.
Quick answers
Who was awarded contract 36C26122F0032?
36C26122F0032 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C26122F0032 worth?
The government has obligated $76,729 on 36C26122F0032. Its potential value, with all options, is $98,000.
Is contract 36C26122F0032 an order under another contract?
Yes. 36C26122F0032 is a delivery order under 36F79721D0259, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C26122F0032 competed?
The extent of competition for 36C26122F0032 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award